Advertisement

 

 

Pharmacogenetic considerations in the treatment of HIV.

Pharmacogenetic considerations in the treatment of HIV.
Author Information (click to view)

Mattevi VS, Tagliari CF,


Mattevi VS, Tagliari CF, (click to view)

Mattevi VS, Tagliari CF,

Advertisement

Pharmacogenomics 2016 12 15()

Abstract

After the introduction of highly active antiretroviral therapy in the 1990s, the perception of the diagnosis of HIV infection gradually shifted from a ‘death sentence’ to a chronic disease requiring long-term treatment. The host genetic variability has been shown to play a relevant role in both antiretroviral drugs bioavailability and adverse effects susceptibility. Knowledge about pharmacogenetics role in HIV infection treatment has largely increased over the last years, and is reviewed in the present report, as well as future perspectives for the inclusion of pharmacogenetics information in the directing of HIV infection treatment.

Submit a Comment

Your email address will not be published. Required fields are marked *

twenty − 19 =

[ HIDE/SHOW ]